Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02036567 · ClinicalTrials.gov registry record

Evaluation of Pain Measurement Device

A clinical trial of Pain, sponsored by Stanford University.

Completed
Registry status
90
Enrollment target
1
Study location

NCT02036567: Completed study of Pain, sponsored by Stanford University.

NCT02036567 is a study of Pain that has completed, run by Stanford University. The registered enrollment target is 90 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02036567, a study of Pain, has completed, sponsored by Stanford University.

COMPLETED
Registry status
90 participants
Enrollment target
1
Study location

Study Summary

This longitudinal observational study will attempt to objectively measure pain with an experimental, non-invasive device. Patients and volunteers will receive a baseline screening with psychophysical tests and questionnaires. Investigators will apply the device to measure pain during routine clinical care and correlate patients pain ratings and analgesia requirements to that measured by the device. A more standardized approach with experimental pain stimuli will be pursued in human volunteer studies.

Conditions Studied

Study Locations (1)

California

  • Department of Anesthesia, Pain and Perioperative Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2014-01
Est. Completion 2017-12
Stanford University

1,744 total trials

What the finished NCT02036567 record still lists

NCT02036567 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (70% lower).

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 0 interventions.

NCT02036567 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02036567 about?

NCT02036567 is a clinical study titled "Evaluation of Pain Measurement Device". This longitudinal observational study will attempt to objectively measure pain with an experimental, non-invasive device. Patients and volunteers will receive a baseline screening with psychophysical tests and questionnaires. Investigators will apply the device to measure pain during routine clinica...

What is the current status of trial NCT02036567?

This trial is currently completed. The enrollment target is 90 participants. The study started on 2014-01. Estimated completion is 2017-12.

What conditions does trial NCT02036567 study?

This clinical trial studies the following conditions: Pain.

Who is sponsoring clinical trial NCT02036567?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02036567 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02036567's enrollment target sits among peer trials

90 182nd of 374 higher than 192 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02036567, the US trial registry maintained by the National Library of Medicine. NCT02036567 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.